[摩洛哥乳腺癌的分子分类] - Suppr

Suppr

超能文献

[Molecular classification of breast cancer in Morocco].

作者信息

Fouad Abbass, Yousra Akasbi, Kaoutar Znati, Omar El Mesbahi, Afaf Amarti, Sanae Bennis

机构信息

Laboratoire des molécules bioactives, Faculté des Sciences et Techniques de Fès, Maroc.

出版信息

Pan Afr Med J. 2012;13:91. Epub 2012 Dec 31.

PMID:23396646

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3567413/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/3567413/195af0baae67/PAMJ-13-91-g001.jpg

相似文献

[Molecular classification of breast cancer in Morocco].

Pan Afr Med J. 2012;13:91. Epub 2012 Dec 31.

[Breast cancer in young patient in Morocco].

Gynecol Obstet Fertil. 2014 Mar;42(3):149-54. doi: 10.1016/j.gyobfe.2011.08.014. Epub 2012 Apr 20.

Prevalence of molecular subtypes and prognosis of invasive breast cancer in north-east of Morocco: retrospective study.

BMC Res Notes. 2012 Aug 13;5:436. doi: 10.1186/1756-0500-5-436.

[Primary neuroendocrine tumors of the breast: a retrospective study of 21 cases and literature review].

Cancer Radiother. 2015 Aug;19(5):308-12. doi: 10.1016/j.canrad.2015.04.003. Epub 2015 Jul 26.

Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma.

World J Surg Oncol. 2008 Oct 22;6:112. doi: 10.1186/1477-7819-6-112.

First report on molecular breast cancer subtypes and their clinico-pathological characteristics in Eastern Morocco: series of 2260 cases.

BMC Womens Health. 2017 Jan 9;17(1):3. doi: 10.1186/s12905-016-0361-z.

[Comparative study of inflammatory and non-inflammatory locally advanced breast cancer - the experience of a Moroccan hospital].

Gynecol Obstet Fertil Senol. 2017 Nov;45(11):604-608. doi: 10.1016/j.gofs.2017.09.005.

[Presentation and outcome of breast cancer under 40 years - A French monocentric study].

Gynecol Obstet Fertil Senol. 2018 Feb;46(2):105-111. doi: 10.1016/j.gofs.2017.12.012. Epub 2018 Feb 1.

Outcome of Breast Cancer in Moroccan Young Women Correlated to Clinic-Pathological Features, Risk Factors and Treatment: A Comparative Study of 716 Cases in a Single Institution.

PLoS One. 2016 Oct 19;11(10):e0164841. doi: 10.1371/journal.pone.0164841. eCollection 2016.

[Epidemiological and biologic profile of breast cancer in Fez-Boulemane, Morocco].

East Mediterr Health J. 2011 Dec;17(12):930-6.

引用本文的文献

Androgen receptor expression in triple negative breast cancer: an Algerian population study.

Libyan J Med. 2025 Dec;20(1):2535778. doi: 10.1080/19932820.2025.2535778. Epub 2025 Jul 20.

Prognostic factors and overall survival of breast cancer in Benin: a hospital-based study.

BMC Womens Health. 2024 May 18;24(1):295. doi: 10.1186/s12905-024-03114-y.

Breast Cancer Phenotypes in Africa: A Scoping Review and Meta-Analysis.

JCO Glob Oncol. 2023 Sep;9:e2300135. doi: 10.1200/GO.23.00135.

Epidemiological and anatomopathological profile of breast cancer in the region of North-West of Tunisia.

Tunis Med. 2021;99(4):441-448.

Male breast cancer: a report of 25 cases.

Pan Afr Med J. 2020 Dec 15;37:343. doi: 10.11604/pamj.2020.37.343.23004. eCollection 2020.

Breast cancer in togolese women: immunohistochemistry subtypes.

BMC Womens Health. 2020 Nov 23;20(1):261. doi: 10.1186/s12905-020-01130-2.

Descriptive study of triple negative breast cancer in Eastern Algeria.

Pan Afr Med J. 2018 Jan 18;29:45. doi: 10.11604/pamj.2018.29.45.12523. eCollection 2018.

Immunohistochemical determination of estrogen and progesterone receptors in breast cancer: relationship with clinicopathologic factors in 302 patients in Ivory Coast.

BMC Cancer. 2017 Feb 7;17(1):115. doi: 10.1186/s12885-017-3105-z.

本文引用的文献

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies.

PLoS Med. 2010 May 25;7(5):e1000279. doi: 10.1371/journal.pmed.1000279.

Protein expression profile and prevalence pattern of the molecular classes of breast cancer--a Saudi population based study.

BMC Cancer. 2010 May 21;10:223. doi: 10.1186/1471-2407-10-223.

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

J Natl Cancer Inst. 2009 May 20;101(10):736-50. doi: 10.1093/jnci/djp082. Epub 2009 May 12.

Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers.

Int J Clin Exp Pathol. 2009;2(5):444-55. Epub 2009 Feb 9.

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

J Clin Oncol. 2009 Mar 10;27(8):1168-76. doi: 10.1200/JCO.2008.18.1024. Epub 2009 Feb 9.

[The use of breast cancer subtype classification to predict local and distant recurrence. A review].

Cancer Radiother. 2008 Nov;12(6-7):577-83. doi: 10.1016/j.canrad.2008.08.272. Epub 2008 Sep 27.

Breast cancer in young women.

J Am Coll Surg. 2008 Jun;206(6):1193-203. doi: 10.1016/j.jamcollsurg.2007.12.026. Epub 2008 Apr 24.

Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.

J Surg Res. 2007 Nov;143(1):109-18. doi: 10.1016/j.jss.2007.03.085.

The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races.

Breast. 2007 Dec;16 Suppl 2:S72-7. doi: 10.1016/j.breast.2007.07.017. Epub 2007 Aug 21.

An overview of prognostic factors for long-term survivors of breast cancer.

Breast Cancer Res Treat. 2008 Feb;107(3):309-30. doi: 10.1007/s10549-007-9556-1. Epub 2007 Mar 22.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验